Does Dr. SMYRNA ABOU ANTOUN have financial conflicts of interest?

Dr. SMYRNA ABOU ANTOUN (MD) has received a total of $390 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $390 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SMYRNA ABOU ANTOUN?

According to CMS Open Payments data, Dr. SMYRNA ABOU ANTOUN received funding from ASTRAZENECA PHARMACEUTICALS ($125), E.R. SQUIBB & SONS, L.L.C ($89), and ABBVIE ($74).

Does Dr. SMYRNA ABOU ANTOUN receive research grants or speaking fees?

Dr. SMYRNA ABOU ANTOUN has received $390 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SMYRNA ABOU ANTOUN

MDReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: WICHITA, KS 67214

NPI Number: 1821297656

LIFETIME INDUSTRY VALUE

$390

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABOU ANTOUN is a verified Internal Medicine practitioner based in WICHITA, KS.

Between 2021 and 2024, Dr. ABOU ANTOUN had an overall industry promotional and research financial footprint of $390 as recorded in the federal CMS Open Payments database.

$390 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABOU ANTOUN's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $125 (representing 32% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$125

32%

E.R. SQUIBB & SONS, L.L.C

Rank 2

$89

22.8%

ABBVIE

Rank 3

$74

18.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.